TFG Asset Management’s Abivax ABVX Stock Holding History

TFG Asset Management’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30,000	Closed	-$2.55M	–	29
2025 Q3	$2.55M	Buy	+30,000	New	+$1.84M	0.34%	29

Other funds holding ABVX

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

TFG Asset Management's ABVX Position: Q4 2025 in Review

TFG Asset Management sold out of Abivax (ABVX) in Q4 2025, closing a stake of 30,000 shares — an estimated $2.55M sold.

TFG Asset Management first reported a position in ABVX in Q3 2025 and held it in 1 quarter. The position peaked at $2.55M in Q3 2025. 247 funds tracked by Wall St. Rank hold ABVX as of Q4 2025.

TFG Asset Management reported no remaining Abivax position as of Q4 2025 after selling out during the quarter.
TFG Asset Management sold 30,000 Abivax shares in Q4 2025, an estimated $2.55M.
TFG Asset Management first reported a position in Abivax in Q3 2025 and held it in 1 quarter.
TFG Asset Management's Abivax position peaked at $2.55M in Q3 2025.
247 funds tracked by Wall St. Rank held Abivax as of Q4 2025.

Based on TFG Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.